Ratings Evonik Industries AG Bulgaria S.E.

Equities

EVK

DE000EVNK013

Real-time Estimate Tradegate Other stock markets 07:45:14 2024-07-17 am EDT			5-day change	1st Jan Change
19.05 ^EUR	+6.77%		0.00%	0.00%

Jul. 16	EVONIK : Deutsche Bank remains its Buy rating	ZD
Jul. 16	EVONIK : Warburg Research reaffirms its Buy rating	ZD

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

With regards to fundamentals, the enterprise value to sales ratio is at 0.8 for the current period. Therefore, the company is undervalued.
The company's share price in relation to its net book value makes it look relatively cheap.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
The company is one of the best yield companies with high dividend expectations.
For the past twelve months, EPS forecast has been revised upwards.
Over the past four months, analysts' average price target has been revised upwards significantly.
Analyst opinion has improved significantly over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company sustains low margins.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
EVONIK INDUSTRIES AG	0.00%	9.67B	-
ECOLAB INC.	+23.61%	70.02B	A-
SIKA AG	-4.46%	47.08B	A-
GIVAUDAN SA	+20.69%	44.25B	B+
FUJIFILM HOLDINGS CORPORATION	+35.36%	29.07B	A-
EMS-CHEMIE HOLDING AG	+4.85%	18.91B	C+
SYMRISE AG	+11.55%	17.15B	B+
CELANESE CORPORATION	-5.06%	16.11B	B+
POSCO FUTURE M CO., LTD.	-28.83%	14.28B	A-
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-29.23%	12.17B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes